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a b s t r a c t
The use of spinal implants for spine fusion has been steadily increasing to avoid the risks of complica-
tions and donor site morbidity involved when using autologous bone. A variety of fusion cages are clin-
ically available, with different shapes and chemical compositions. However, detailed information about
their surface properties and the effects of such properties on osteogenesis is lacking in the literature.
Here we evaluate the role of surface properties for spinal implant applications, covering some of the
key biological processes that occur around an implant and focusing on the role of surface properties,
specifically the surface structure, on osseointegration, drawing examples from other implantology fields
when required. Our findings revealed that surface properties such as microroughness and nanostruc-
tures can directly affect early cell behavior and long-term osseointegration. Microroughness has been
well established in the literature to have a beneficial effect on osseointegration of implants. In the case
of the role of nanostructures, the number of reports is increasing and most studies reveal a positive
effect from the nanostructures alone and a synergistic effect when combined with microrough surfaces.
Long-term clinical results are nevertheless necessary to establish the full implications of surface
nanomodifications.
 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
1. Introduction
Musculoskeletal diseases such as back pain, arthritis and bone
fractures have been recognized as the most reported health condi-
tion in the United States, amounting to almost 8% of the US gross
domestic product in lost wages and healthcare-related costs [1].
In the case of chronic back pain, spinal fusions have become a via-
ble treatment to eliminate pain and restore a patient’s quality of
life [2–4]. Autologous bone grafts are the gold standard filler for
orthopaedic surgeries because of their osteogenic capabilities, but
increased complications and morbidity of the donor site have
shifted the focus to graft substitutes and spinal implant devices
[5,6]. With an aging population in the United States, there is a
pressing need for surgical approaches that can capitalize on the
intrinsic regenerative capacity of mineralized tissues to provide a
more permanent treatment.
The modern use of metallic and polymeric implants for ortho-
paedic and dental applications has been evolving for the last
60 years, with major advances coming from the dental implant
field [7–10]. Originally, endosseous implants were expected to per-
form their job simply through a mechanical anchorage with bone.
Early efforts had relatively high failure rates, in part due to the
layer of fibrous connective tissue that grows between the bone
and the implant [11] (Fig. 1B). The formation of the fibrous capsule,
thought to be an inevitable consequence of the implantation proce-
dure [12,13], can start a vicious cycle of micromotion and inflam-
mation around the implant that eventually leads to osteolysis
and implant failure [14–16]. To achieve long-lasting and successful
outcomes, strong and direct interaction between the bone and the
implant surface is required [7,17]. Such direct contact between the
bone and the implant surface defines osseointegration and is the
current goal of a successful bone implantation procedure (Fig. 1C).
In the orthopaedic implant field, several reports have found
fibrous capsules around implants of metallic [18,19] or polymeric
nature [20–22]. This type of failure is commonly attributed to toxic
wear debris phagocytosed by macrophages and other cells of the
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surrounding tissue [23–25]. However, several cases that resulted in
fibrous encapsulation of implants did not present detectable traces
of wear debris [26,27] but still elicited an aseptic inflammatory
response that could lead to osteolysis [14]. Most of these cases
involve polymeric or metallic implants with smooth surfaces
[27–29]. From experiences in the dental field, however, it is now
well accepted that the presence of a fibrous layer can be avoided
by controlling the surface properties of the implant, such as
increasing the surface microroughness, to promote bone apposi-
tion directly onto the implant surface [30–33].
The process of osseointegration involves a complex chain of
events, from protein adsorption and blood clotting at the implant
surface to site infiltration and biological recognition of the surface
by mesenchymal stem cells (MSCs) and osteoblasts, finally leading
to bone formation by these cells at the interface, thus creating an
intimate bond between the bone and implant [32,34]. These events
are directly and indirectly affected by the surface properties of the
device, making them key determinants of the implant’s outcome
in vitro, in vivo and clinically [35–37] (Fig. 2).
A variety of fusion cages are clinically available, with different
shapes and chemical compositions. However, detailed information
about their surface properties and the effects of such properties on
osteogenesis is lacking in the literature. Additionally, no systematic
reviews are available on the role of surface properties for spinal
implant applications. Thus, this review will cover some of the
key biological processes that occur around an implant, focusing
on the role of surface properties, specifically the surface structure,
on osseointegration, drawing examples from other implantology
fields when required. Other factors that may influence the outcome
of the implant, such as surgical technique, patient’s record and
implant shape, have been reviewed elsewhere [38–40].
2. Osseointegration: key biological processes
2.1. Wound healing and fibrin clot formation
The process of osseointegration involves several biological
events that determine the mechanical stability and outcome of
the implant. One of the first events to occur when an implant is
placed in the body is the adsorption of water molecules, proteins
and lipids from the blood to the surface of the device [41,42]. The
specific protein profile presented on the surface will depend on
the surface properties of the implant. Many proteins present in
blood may interact with the implant’s surface, some of which
are associated with the host inflammatory response, such as
fibrinogen and complement molecules, as well as other proteins
involved in cell attachment, such as fibronectin and vitronectin
[42–44]. The attachment of blood platelets and the subsequent
release of their inner contents promotes the formation of fibrin
clots that serve as an immature meshwork to fill voids and facil-
itate cell migration towards the surface of the implant [45]
(Fig. 3). The surface coverage and strength of attachment of the
fibrin clots to the implant surface depends on implant surface
properties [46,47]. One hypothesis suggests that increasing the
surface roughness enhances the strength of the fibrin clot
attachment, which is important in withstanding the forces of cells
moving along and pulling these fibrin fibers, thereby promoting
wound contraction [48]. Other reports propose that increasing
the surface roughness supports greater amounts of fibrin clot
extension on the surface, promoting a better wound healing
response [46].
Some of the first cells to arrive at the implantation site are neu-
trophils and macrophages, which clean the wound site from possi-
ble pathogens and necrotic tissue [49,50]. Other important cell
types to colonize the implantation site include MSCs from blood
and bone marrow [47,51]. These cells have the motility and enzy-
matic activity to travel through dense fibrin clots on their way to
the surface of the implant [52], where they will be exposed to
inflammatory cytokines and growth factors conducive to wound
healing and tissue regeneration [53] (Fig. 3). MSCs have the poten-
tial to differentiate into several cell types, such as osteoblasts,
chondrocytes and fibroblasts, depending on the biological environ-
ment and the implant surface properties [53,54]. However, the fate
of stem cells around osseous implants seems to be biased towards
the formation of bone tissue, with some soft tissue being formed at
the interface between the bone and the implant, depending on the
surface characteristics of the implant. Thus, by the time the MSCs
Fig. 1. Schematic of (A) a normal joint, (B) a failed implant and (C) a fused and osseointegrated implant.
Fig. 2. Diagram showing the direct and indirect interactions between surface properties (e.g. surface roughness, surface energy, surface chemistry) and biological events, such
as protein adsorption and osteoblast response (e.g. proliferation, differentiation, bone mineralization).
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reach the surface of the implant, they might have already set in
motion the differentiation machinery necessary to become pre-
osteoblasts and start forming bone.
2.2. Mimicking bone structure: bone remodeling
Once the implant has been stably fixed in the bone, with the
fibrin meshwork firmly established, bone can form on two differ-
ent fronts: on the surface of the bone surrounding the implant (dis-
tance osteogenesis) and directly on the surface of the implant
(contact osteogenesis) [48]. Depending on the surface characteris-
tics, the differentiating osteoblasts reaching these two fronts will
either proliferate for a few cycles or begin laying down a non-col-
lagenous assortment of proteins that initiates mineralization called
lamina limitans, or ‘‘cement line’’ [55–57]. The cement line, rich in
proteins like osteopontin, bone sialoprotein and proteoglycans
[34,58,59], further promotes osteoblast recruitment and matura-
tion. Contact osteogenesis is required for successful osseointegra-
tion, and should be promoted by the implant.
The next stage in the osseointegration process requires a bone
remodeling cycle in which osteoclasts resorb the newly formed
bone to resolve microcracks and prime the surface for new bone
formation [60,61]. Osteoclasts acidify the mineralized matrix just
underneath their ruffled membranes, dissolving calcium phos-
phate crystals and creating microscale resorption lacunae that
are 30–100 lm in diameter [62,63]. Osteoclasts, however, do not
produce collagenase, an enzyme required to degrade collagen
[60]. Thus, resorption lacunae have various submicro- and nano-
scale features created by the collagen tufts and fibers left by osteo-
clasts, giving bone a high degree of structural complexity. This
nanotopography, with its inherent biochemical information, could
be the signal that osteoblasts require when looking for a surface
that requires new bone formation. The concept of mimicking the
hierarchical structure of bone on implant surfaces by including
nanostructures on commercially available devices originates from
this observation (Fig. 4).
If the surface properties of the implant are not selected appro-
priately, the invading cells can form a layer of fibrous tissue
between the implant and the bone that jeopardizes the outcome
of the procedure. The lack of bone attachment to such an implant
generates a vicious cycle that starts with micromotion and
inflammation and ends with thickening of the fibrous layer,
degradation of the surrounding bone and loosening of the
implanted device [14,26,27]. Interestingly, tailoring the surface
properties of implants can help avoid these failed outcomes.
3. Osseointegration and implant surface structure
Because certain patient conditions, such as old age, poor bone
quality and smoking, can jeopardize the success of the implanta-
tion surgery [40], the goal is to design implants in such a way as
to minimize the effect of patient variables and improve the success
rate. Much attention is paid to the macroshape of an implant to
produce good primary fixation and to the bulk chemical composi-
tion of the implant to provide the mechanical properties required
for the application. While these macroscale aspects are important,
surface characteristics at the micro-, submicro- and nanoscale
must be considered at the same time to ensure successful and
long-term osseointegration. A loose definition of micro-, submi-
cro-, and nano- applies to features having at least one of their
dimensions (i.e. height, length, width) smaller than 100 lm,
1 lm or 100 nm, respectively. More stringent evaluations apply
the aforementioned thresholds to all dimensions of the feature.
Notably, such small surface structures are invisible to the naked
eye and require specialized equipment to quantify them, such as
electron microscopy [64], laser confocal microscopy [65] or atomic
force microscopy [66].
In the dental and orthopaedic fields, implants are commonly
made out of metals, with titanium and its alloys being widely used
for dental implant applications due to their suitable weight-to-
strength ratio and good biological performance. Interestingly, the
surface chemistry of an implant can be quite different from its bulk
chemistry. Titanium spontaneously forms a thin oxide layer that
inhibits further corrosion of the implant. This oxide layer, which
is ceramic in nature, is suggested to provide titanium’s good bio-
logical performance by mimicking the ceramic properties of
hydroxyapatite in bone [30]. However, the topography of the sur-
face, regardless of the chemistry, still requires attention to enhance
the process of osseointegration.
In the case of spinal implants, polyetheretherketone (PEEK) has
become a popular bulk material for spinal cage manufacturing due
to itsmechanical properties,which canbe tailored to resemble those
of bone, and its low radio-opacity when compared to metals [20].
Although attractive, these properties are not required for successful
osseointegration. Furthermore, PEEK promotes the formation of a
fibrous layer between the bone and the implant [21,22]. The ortho-
pedic industry has attempted to overcome this fibrous encapsula-
tion through the use of different surface modifications, such as
coating the PEEK surfacewith titanium [67–69]. A vast body of liter-
ature related to the surface modification of Ti and Ti alloy implants
supports its importance for successful osseointegration, as dis-
cussed below. However, reports on the surfacemodification of PEEK
are not as readily available in the literature or are still proprietary, so
the clinical value of these modifications is not yet established.
3.1. Microroughness effect in vivo
Most commercially available implants in the dental field con-
tain some type of surface modification to increase their surface
roughness. This is in part due to the large number of studies show-
ing beneficial results of microroughness in vitro, in vivo and clini-
cally [10,31,36]. Several surface modification techniques exist to
increase microroughness, such as acid etching, sand blasting, heat
treatments and anodic oxidation, as well as the combination of any
of these treatments (Fig. 5). The surface topography created by
these different microstructuring treatments will vary greatly and,
although seldom compared with each other, they commonly
enhance the process of osseointegration when compared to rela-
tively smooth surfaces [70].
In one study, machined, relatively smooth pedicle screws were
compared to grit-blasted, microrough screws, both made out of
Fig. 3. Schematic depicting fibrin clot adhesion to a rough surface and MSC
migration through the clot. The MSCs pull on the fibrin clot to reach the surface of
the implant, and at the same time are exposed to several inflammatory cytokines
and growth factors that can influence their differentiation state.
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titanium alloy (Ti6Al4V), in a sheep spine model after 12 weeks of
healing [70]. Implant osseointegration was assessed by microcom-
puted tomography (micro-CT) and histomorphometry. The results
from the micro-CT showed that both machined and grit-blasted
implants were surrounded by bone. However, the resolution of
the micro-CT was not sufficient for detailed judgement of the
bone–implant interface. Through histomorphometrical analysis, a
higher incidence of soft tissue between the bone and the machined
surface was found when compared to the grit-blasted surface, and
this observation was correlated to a higher bone-to-implant
contact (BIC) percentage for grit-blasted implants (73.5 ± 28.5%)
vs. machined ones (59.6 ± 25.8%). Moreover, the force necessary
to pull the screws out was four times as great for the grit-blasted
implants than for the machined implants.
Similar results are abundant in the literature and show
enhanced osseointegration on microrough surfaces with very dif-
ferent topographies, from simple uniform micropatterns [71] to
more complex restructured surfaces [72], compared to machined
surfaces as measured by BIC and mechanical testing [73,74].
However, the type (e.g. sharp peaks, grooves, pores) and degree
Fig. 4. Interactions between the bone and the implant surface at different length scales. At the macroscale, the implant should provide a good mechanical fixation with bone.
At the microscale, micro- and submicrofeatures presented on the surface can directly interact with osteoblasts and mesenchymal stem cells. At the nanoscale, cell membrane
receptors, such as integrins, can recognize proteins adsorbed on the surface, which in turn are modulated by the nanostructures on the surface. Figure used with permission
from Ref. [115].
Fig. 5. Schematic and SEM images of different examples of surface modification treatments that can be applied to machined implants, including acid etching, grit blasting and
heat treatment. SEM scale bar = 3 lm.
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of microroughness (as quantified by surface roughness measure-
ments) can affect the early healing and long-term success of the
implant [75,76].
Surfaces with complex microtopography appear to be even
more osteogenic than surfaces with only one type of roughness.
Acid-etched titanium surfaces were compared to sand-blasted
and acid-etched surfaces in a pig maxilla model after 10 weeks of
healing [77]. Both treatments increased surface microroughness,
but the sand-blasted and acid-etched surfaces had a considerably
higher roughness average (Ra = 1.53 ± 0.11 lm) than the just
acid-etched surfaces (Ra = 0.90 ± 0.11 lm). The authors reported
that both surfaces had the ability to interlock with bone, but the
removal torque force on the sand-blasted and acid-etched implants
was significantly higher (157.29 ± 38.04 N) than on the acid-etched
implants (105.33 ± 25.12 N).
3.2. Microroughness effect in vitro
A series of well-controlled studies using Ti substrates generated
using photolithography to create microscale craters and modified
using acid etching or anodization to create submicron scale and
nanoscale features showed that osteoblast lineage cells exhibit
specific preferences for microstructure and nanostructure ele-
ments with respect to osteoblastic differentiation [78,79]. These
in vitro experiments indicated that a complex topography charac-
terized by 30 lm diameter craters superimposed with irregular
pits and peaks approximately 3 lm in diameter elicited the most
differentiated osteoblast phenotype. Moreover, cells could
discriminate between the more pointed nanoarchitecture created
by acid etching and the more rounded nanofeatures created by
electrochemical anodization, even though the peak heights were
comparable, exhibiting a more differentiated phenotype on the
acid-etched surface.
The favorable response elicited by microrough implants in vivo
has been attributed to the activation of several important signaling
pathways in osteoblasts and MSCs in vitro. Once these cells come
into contact with a surface, whether a bone surface that has been
resorbed by osteoclasts or an implant surface, they go through a
progression of well-defined phases, including proliferation, differ-
entiation and, in some cases, apoptosis. These phases are transcrip-
tionally regulated, meaning that the genetic and protein profiles
during each phase are distinct [80]. The duration of each phase
and the cell response with respect to osteoblastic differentiation
are determined by the surface properties of the device.
A key observation in vitro has been that osteoblasts and MSCs
after 5–7 days of culture on microrough surfaces in vitro have
lower cell numbers and higher levels of differentiation markers,
such as alkaline phosphatase and osteocalcin, when compared to
relatively smooth surfaces [70,79,81]. Alkaline phosphatase is an
enzyme produced early during osteoblast differentiation and is
important for the onset of mineralization, whereas osteocalcin is
a late differentiation marker produced at high levels during the
mature state of the osteoblast [82,83]. The decrease in cell number
and increase in differentiation markers agree with the normal pro-
gression of osteoblast differentiation, indicating that cells growing
on the microrough surfaces exit the proliferation phase earlier to
start differentiating and producing the proteins necessary for bone
formation.
Osteoblasts do not interact directly with the surface of the
implant but can sense the changes in surface properties by
identifying the layer of adsorbed proteins from the surrounding
environment using cell membrane receptors such as integrins
[84,85]. Integrins are composed of a and b subunits, which can
bind specific proteins in the extracellular matrix and start signaling
cascades within the cell [85]. Microroughness has been shown to
influence the types of integrins that are produced by the cells,
promoting those subunits associated with bone proteins, such as
a2 and b1, but not those subunits associated with soft tissue pro-
teins, such as a5 or av [86]. Thus, microroughness can affect the
progression of the osteoblast phenotype by up-regulating integrins
such as a2b1, which directly regulates osteoblast differentiation
and local factor production [86].
Additionally, healthy bone growth and regeneration requires a
healthy vasculature that develops in intimate association with
osteoblasts to supply oxygen, nutrients and other factors that can
enhance bone formation [87,88]. In turn, osteoblasts can promote
the formation of blood vessels through secretion of angiogenic fac-
tors, such as vascular endothelial growth factor and fibroblast
growth factor 2, which can be enhanced by an increase in surface
microroughness [89]. Other important factors secreted by osteo-
blasts during implant osseointegration that can be enhanced by
adjusting surface microroughness include bone morphogenetic
proteins [90], transforming growth factor-b 1 and 2 [91], and Wnts
[92]. Importantly, these factors are soluble and their signaling is
required for bone development [93–95]. Experiments in which
osteoblasts are grown on Ti substrates in a co-culture system
where MSCs are grown on standard tissue culture plastic show that
the soluble factors produced by the osteoblasts are able to induce
MSC osteoblastic differentiation [54]. These observations help
explain how the formation of bone on a microtextured implant
in vivo can impact bone formation within the bone bed distal to
the implant.
Cells on microtextured surfaces also produce factors that mod-
ulate bone resorption. By producing increased levels of osteopro-
tegerin, the cells can control the number and activity of
osteoclasts [96], thereby promoting net new bone formation over
bone remodeling during healing. In addition, cells that are cultured
on microtextured Ti produce higher levels of anti-inflammatory
cytokines and lower levels of pro-inflammatory cytokines than
cells on smooth surfaced Ti [97]. Thus, cells on an implant surface
can also impact the overall environment in which bone healing is
occurring.
Unfortunately, even with an increase in surface microrough-
ness, implant failure still occurs in challenging cases, such as those
with patients compromised by disease or age [98]. Thus, other key
characteristics, such as surface energy and surface nanotopogra-
phy, may be manipulated and, when combined with surface
microroughness, can synergistically promote bone formation in
direct contact with the implant, especially in cases of patients with
compromised bone [31,99].
3.3. Role of nanostructures in vivo
In recent years, a number of studies have been published that
report the beneficial effects of adding nanostructures to implants
in vivo [100–102]. However, most surface nanostructural modifica-
tions introduce changes to other implant characteristics, such as
surface chemistry and surface energy, thus complicating the eval-
uation of the influence of these nanostructures on cell response
[103,104]. Regardless, we will focus on the outcomes of reports
suggesting that nanostructures can be attractive features to incor-
porate into clinical implants, highlighting these limitations when
necessary.
Machined, relatively smooth titanium surfaces have been com-
pared to nanostructured surfaces in a rat tibial model for up to
56 days [101]. The nanomodification process used for this study
involved depositing oxide nanoparticles on the surface of the
implant through a sol–gel technique without affecting the overall
microroughness. The oxide nanoparticles used for the coating
included different crystalline phases of TiO2 (i.e. anatase, rutile),
as well as zirconia (ZrO2), introducing changes to either crystal
structure or chemistry, respectively, when compared to the
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machined control. No differences were found between the nano-
structured implants compared to the machined control when eval-
uating removal torque forces up to 56 days after implantation.
However, the BIC for all nanomodified implants was higher than
the machined control. These results were correlated to quantitative
polymerase chain reaction data that showed higher mRNA levels of
osteoblastic differentiation markers, such as osteocalcin and oste-
opontin, in the bone surrounding the nanostructured implants.
Nanomodified implant materials have also been compared to
microrough implants in vivo. For these experiments, nanomodified
coin-shaped implants were assessed against grit-blasted implants
in a rabbit tibial model after 4 weeks [100]. Electrochemical anod-
ization in hydrofluoric acid and annealing (550 C) was used to cre-
ate well-defined anatase nanotubes on the surface of the test
implants. The nanomodification altered the crystal structure, as
reported, and possibly the surface chemistry by incorporating
traces of F from the anodization treatment, though the latter was
not evaluated. In addition to possible differences in surface chem-
istry resulting from the anodization process, other differences
related to the initial surface microtexture of the test materials
were not controlled. Within the constraints of these experimental
parameters, however, the results showed that the pull-out force for
nanotube implants was considerably higher than for control
implants, and these results were corroborated by histological sec-
tions that showed increased BIC percentages on nanotube surfaces
when compared to controls. Chemical mapping of the pulled-out
surfaces by energy-dispersive X-ray spectroscopy also provided
confirmation of greater bone being retained on the nanomodified
surfaces, confirming that there was greater BIC causing the fracture
to occur within the peri-implant bone and not at the bone–implant
interface.
The ultimate goal in implant design is to mimic bone hierarchi-
cal structure at all different length scales (i.e. macro-, micro-,
submicro- and nano-), and this has also been assessed by adding
nanostructure to already microrough implants. The performance
of sand-blasted Ti alloy (Ti–15Mo–5Zr–3Al) implants was com-
pared to that of sand-blasted and nanomodified implants in a rat
femoral model for up to 8 weeks [102]. In this particular case,
the nanomodification was termed nanobimorphic because of the
presence of what the authors called nanotrabecular and nano-
tuft-like structures on the surface, created by alkali (NaOH) and
heat (600 C) treatments. The modification introduced surface
chemical changes by increasing the oxygen content and the O/Ti
ratio. Biomechanical evaluation found that push-in forces for the
sand-blasted and alkali- and heat-treated implants were
significantly higher after 1, 2, 4 and 8 weeks when compared to
sand-blasted-only implants. These results were also confirmed by
the greater CaP content and by histomorphometrical analysis
showing more BIC after 4 weeks of implantation on the surface
of the extracted nanomodified implants.
Taken together, these different studies support the concept of
adding nanostructures to both microsmooth and microrough
implants to improve the early healing and long-term osseointegra-
tion of implants for bone applications.
3.4. In vitro response to nanostructures
The phenomena seen in vivo of more BIC and higher forces dur-
ing biomechanical testing on nanostructured implants have been
attributed to enhanced activity at the cellular level by osteoblasts
and MSCs. Although few studies have been published questioning
the influence of nanostructures on cell behavior [105], many other
reports have shown that osteoblasts are indeed sensitive to these
small features and can respond strongly to them. Morphological
evaluations of cells growing on nanomodified substrates compared
to nanosmooth controls show more filopodia extensions and actin
cytoskeletal alignment [106,107], as well as enhanced cell adhe-
sion [108]. This response can be associated with the fact that the
spacing of adhesion sites on a surface can regulate integrin binding
to the extracellular matrix (ECM), with a spacing of less than 54 nm
promoting the formation of focal adhesion complexes important
for cell signaling and recognition of the ECM [109].
Cell spreading and attachment assays by themselves, however,
are not sufficient to establish the beneficial role of nanostructures
for bone formation. Studies looking at the differentiation state of
osteoblasts growing on nanostructured surfaces have found higher
mRNA production of osteoblast markers, such as osterix, alkaline
phosphatase and osteocalcin [110]. The final protein levels of these
markers have also been shown to increase on nanomodified
surfaces compared to on nanosmooth surfaces, confirming the
influence of nanostructures on osteoblast phenotype [79,111].
For clinical applications, the addition of nanostructures to
microrough implants is the most attractive option for surface mod-
ifications to take advantage of the already demonstrated enhance-
ments of microroughness and to couple them to the improvements
generated by nanostructures. Yet cellular response is rarely linear,
thus assessment of the effects of such a combination of micror-
oughness and nanostructures at the cellular level is required.
Indeed, reports show synergistic effects in terms of enhanced
osteoblast interactions with the surface, as well as higher mRNA
and protein production of markers for osteoblast differentiation
on the combined microrough and nanostructured surfaces when
compared to just microrough surfaces [112–115].
Studies performed by our group using a heat treatment modifi-
cation to superimpose nanostructures onto relatively flat or micro-
rough Ti substrates corroborated these findings [115]. Our results
showed a modest effect on osteoblast response by nanostructures
on flat substrates compared to unmodified flat controls, while the
superposition of nanostructures onto microrough surfaces syner-
gistically enhanced the production of osteoblast differentiation
markers and local factors important for bone formation compared
to unmodified microrough controls. These results suggest that
osteoblasts are very sensitive to the hierarchical structure of their
surface for the production of new bone.
Osteoblasts have been consistently shown to respond to nano-
structures by increasing production of differentiation markers
and other local factors [114,115]. MSCs, usually isolated from bone
marrow and treated with osteogenic induction media to drive
them into osteoblastic differentiation, have also been assessed
and confirmed to respond to nanostructures [113]. In addition,
MSCs have been shown to be directed towards osteoblastic differ-
entiation by microstructures even when not exposed to osteogenic
media or other inductive factors in the culture medium [54]. Inter-
estingly, when MSCs are cultured without osteogenic media on
nanostructured surfaces, their fate seems to depend on other fac-
tors. Randomly displaced patterns of nanostructures on polycapro-
lactone substrates, without the use of soluble factors, can drive
MSCs to produce osteogenic markers to similar levels as those trea-
ted with osteogenic media on flat substrates, while highly ordered
patterns may prevent spontaneous MSC osteoblastic differentia-
tion and promote the maintenance of MSC stemness rather than
differentiation [116].
The idea that such small changes can be so influential is fasci-
nating and the concept of maintaining MSC stemness can be exten-
sively exploited in the field of tissue regeneration and the
manipulation of stem cells. However, these results also indicate
that many questions remain to be answered in the quest to incor-
porate nanostructures in clinical implants. While in vivo studies in
the literature report that topographically hierarchical surfaces pro-
mote osseointegration [102] and our previous results have shown
that combined micro/nanorough surfaces synergistically enhance
osteoblast differentiation [115], other studies by our group on
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either commercially pure Ti or Ti alloy (Ti6Al4V) have shown that
MSCs may be behaving differently than committed osteoblasts on
these hierarchical surfaces [117,118]. These results may provide an
insight into the biological complexity surrounding a healing
implant. The positive in vivo results can be considered a good first
step to bringing these surface modifications closer to the clinics,
but not until long-term clinical studies are performed will the full
implications of these different surface features on the performance
of implants for bone applications be completely understood.
4. Summary
In summary, the success of spinal implants is largely dependent
on the surface characteristics of the device (e.g. surface roughness,
surface chemistry, surface energy), as much as it is dependent on
the macrodesign of the implant, the experience of the physician
and patient variables. A complex chain of biological effects that
ends with the differentiation of osteoblasts and the production of
bone on the surface of the implant is required to achieve successful
osseointegration, and this biological response can be modulated by
the properties of the implant surface. Surface microroughness is
one of the surface characteristics of an implant that has been well
established as a tool to achieve better osseointegration, as has also
been confirmed and explained in vitro. More recently, nanotopog-
raphy has been evaluated and applied to implants to better mimic
the endogenous structure of bone, with very promising results in
terms of osteoblast maturation and bone formation. Experiments
with MSCs on nanostructured surfaces without osteogenic media
are providing great insights and revealing a complex story of cellu-
lar diversity for the success of an implant. Understanding the
effects of surface properties on cell response is of utmost impor-
tance to the design implants that can provide a robust solution
by minimizing patient and clinical variables.
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